Menu
2025 Session

Budget Amendments - HB1600 (Committee Approved)

View Budget Item
View Budget Item amendments

Reduce Cost of Insulin

Item 101 #2h

Item 101 #2h

First Year - FY2025 Second Year - FY2026
Commerce and Trade
Economic Development Incentive Payments FY2025 $4,500,000 FY2026 $0 GF

Language
Page 104, line 21, strike "$100,022,331" and insert "$104,522,331".

Page 108, after line 9, insert:

"V. Out of this appropriation, $4,500,000 the first year from the general fund is provided to the Virginia Economic Development Partnership Authority to support a non-profit operating a pharmaceutical manufacturing facility that will accelerate the development of a fast-acting insulin to increase access and affordability for Virginians. Prior to any funds being disbursed, the authority shall enter into a Memorandum of Understanding (MOU) with a non-profit organization that includes performance objectives related to the availability of a fast-acting biosimilar insulin in the Commonwealth. The MOU shall identify: (i) performance objectives agreed to by both parties including a price of not more than $30 per vial and not more than $55 for five pre-filled insulin pens, (ii) estimated savings to residents of the Commonwealth from purchase of low-cost insulin;  (iii) estimated potential savings to the Commonwealth as a self-insured employer from the availability of affordable insulin manufactured at a non-profit facility in Virginia; and (iv) this non-profit shall cause or cause to be made a matching amount of not less than $5,000,000 for the project. The authority shall not require the achievement of the performance metrics outlined in the MOU prior to the release of these funds to an eligible non-profit company. Any funding remaining at the end of the fiscal year shall be carried forward into the next fiscal year for the purposes described in this paragraph."



Explanation

(This amendment provides $4.5 million to invest in the development of a fast-acting insulin to reduce the cost of this drug for consumers to no more than $30 per vial.)